AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Close
Create a link to this page
Copy and paste this link tag into your Web page or blog:
<a href="http://www.accessmylibrary.com/coms2/summary_0286-14817561_ITM" title="Facts and information about Marketing approval in Europe granted to Cubicin.(PIPELINE PREVIEWS)">Marketing approval in Europe granted to Cubicin.(PIPELINE PREVIEWS)</a>
Close
Set up an RSS feed that alerts you when new articles from Journal of Drugs in Dermatology are available.
Frequently asked questions about RSS feeds
Marketing approval in Europe granted to Cubicin.(PIPELINE PREVIEWS)
Chiron Corporation recently announced that Cubicin (daptomycin) was granted marketing approval by the European Commission. The FDA approved Cubicin in September of 2003 for the treatment of complicated skin and soft-tissue infections. Cubicin is an IV antibiotic that is indicated for the treatment of those infections that are caused by Gram-positive bacteria. This drug has a unique mechanism of action that prevents it from being susceptible to typical methods of antibiotic resistance employed by certain bacteria. Cubicin belongs to a novel class of antibiotics known as cyclic lipopeptides, which act by binding to cell membranes of Gram-positive bacteria, thereby ...
Related articles from newspapers, magazines, journals, and more
For more facts and information, see all results
- Cubicin(R) Granted Marketing Approval in Europe; First-in-Class Antibiotic...
- Press release article from: Business Wire January 23, 2006 700+ words
...European Commission has granted marketing approval for CUBICIN(R) (daptomycin), a...class IV antibiotic. The marketing approval was granted in the 25 member...Norway. Under the approval, CUBICIN is indicated for the treatment...
- Cubist Pharmaceuticals Begins Shipping Cubicin to U.S. Institutions.
- Press release article from: Business Wire November 4, 2003 700+ words
...shipping its flagship antibiotic product, Cubicin(TM) (daptomycin for injection), to...S. Food & Drug Administration marketing approval for CUBICIN on September 12, 2003. CUBICIN is indicated for the treatment of complicated...
- Cubist Pharmaceuticals begins shipping Cubicin to the US institutions.
- News wire article from: Asia Africa Intelligence Wire November 4, 2003 700+ words
...shipping its flagship antibiotic product, Cubicin (daptomycin for injection), to US hospitals...received US Food & Drug Administration marketing approval for Cubicin on 12 Sep 2003. Cubicin is indicated for the treatment of complicated...
- Chiron launches Cubicin in EU.(European Union's European Commission approves...
- Newspaper article from: Pharma Marketletter January 30, 2006 700+ words
...European Commission has granted marketing approval for Cubicin (daptomycin), a first...intravenous antibiotic. The marketing approval was granted in the 25 member...Norway. Under the approval, Cubicin is indicated for the treatment...
- CUBICIN Approved for S. aureus Bloodstream Infections in South Korea and Taiwan.
- Press release article from: Business Wire August 1, 2007 700+ words
...NASDAQ: CBST) today announced that CUBICIN([R])(daptomycin for injection...structure infections (cSSSI) and SAB/RIE. CUBICIN was previously approved in Taiwan (in...received by Kuhnil Pharmaceutical Corp. (CUBICIN marketing partner for South Korea) and...
- FDA Approves Cubicin, Previously Cidecin, an Antibiotic Developed by Cubist...
- Press release article from: Business Wire September 12, 2003 700+ words
...Drug Administration (FDA) has approved Cubicin(TM) (daptomycin for injection; previously...by early November. "The approval of CUBICIN is particularly important as we face the...become less effective. The approval of CUBICIN gives physicians a new weapon against...
- FDA Accepts CUBICIN(R) sNDA and Grants Priority Review.
- Press release article from: Business Wire November 21, 2005 700+ words
...Application (sNDA) for Cubist's antibiotic CUBICIN(R) (daptomycin for injection) has...By granting priority review status to CUBICIN, the FDA has established a target date...March 24, 2006. Cubist submitted the CUBICIN sNDA on September 26, 2005, requesting...
- IV Antibiotic CUBICIN Approved for Marketing in Canada.
- Press release article from: Business Wire September 25, 2007 700+ words
...NASDAQ: CBST) today announced that CUBICIN[R](daptomycin for injection) is...Pharmaceuticals, Inc. (Oryx) has licensed CUBICIN for the Canadian market from Cubist...commercial launch of the drug, and expect that CUBICIN will quickly become an essential part...
- Cubist Pharmaceuticals' CUBICIN Approved for Additional Indications in the EU.
- Press release article from: Business Wire September 6, 2007 700+ words
...CBST) said today that its IV antibiotic CUBICIN[R](daptomycin for injection) is...other parts of the world for marketing CUBICIN, is based on data from Cubist's landmark...and soft-tissue infections (cSSTI). CUBICIN was originally approved by the European...
- $40-50 MILLION IN CUBICIN SALES PROJECTED FOR 2004.(Cubist Pharmaceuticals Inc.)
- Newspaper article from: Biotech Financial Reports May 1, 2004 700+ words
...information on the launch of its flagship product, Cubicin (daptomycin for injection). CUBICIN was launched in November 2003 in the U.S...comfortable providing an expected range for CUBICIN sales this year. Based on our confidence in...
Source: HighBeam Research, Marketing approval in Europe granted to Cubicin.(PIPELINE PREVIEWS)